Poor nocturnal sleep is independently associated with a substantially higher risk of metabolic dysfunction-associated steatotic liver disease (MASLD) in adults with type 2 diabetes (T2D), according to a study published online June 22 in Diabetology & Metabolic Syndrome.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗